Wednesday, March 19, 2014
inVentiv Clinical Trial Recruitment Solutions (iCTRS), offering solutions to overcome the costly obstacles that delay clinical trials, has partnered with ViS Research, an online feasibility platform using interactive visualizations, to revolutionize and speed the antiquated system of clinical trial site evaluation.
The WIRB-Copernicus Group, the world’s largest provider of regulatory and ethical review services for human research, has partnered with Mytrus, a clinical technology and services company, to deliver a unique electronic informed consent solution that will help to streamline and enrich the clinical research process.
The University of Alabama at Birmingham (UAB) will use an iPad application developed by Mytrus, a clinical technology and services company for medical and pharmaceutical research, in an upcoming pilot study supported by the U.S. Department of Health & Human Services Agency for Healthcare Research and Quality.
Mytrus, a San Francisco-based innovative clinical technology and services company, announced that its iPad application explaining informed consent prior to clinical trial patient enrollment has been selected for use in a global, multi-year study supported by the National Institute of Neurological Disorders and Stroke (NINDS).
Greenphire, based in suburban Philadelphia, and San Francisco startup Mytrus have developed web-based solutions to streamline the arduous tasks of recruiting, retaining, and efficiently administering clinical trials. Greenphire’s ClinCard System, a web-based patient payment, management, and communication platform, compliments the functionality offered by Mytrus and its innovative methods for allowing patients to participate in clinical research studies directly from their own homes.
As Pfizer begins enrolling the first-ever FDA-approved “virtual” clinical trial, which allows patients to participate from home using smartphones and computers instead of visiting a clinic, industry executives believe the study has far-reaching implications for improving the productivity of clinical trials in the future.